Mitesh

/Mitesh

About Mitesh

This author has not yet filled in any details.
So far Mitesh has created 301 blog entries.

MHRA Drug Safety Update: Nasal decongestant sprays and drops containing xylometazoline hydrochloride / oxymetazoline hydrochloride

Nasal decongestant sprays and drops containing xylometazoline hydrochloride / oxymetazoline hydrochloride: increased risk of rebound congestion, rhinitis medicamentosa, and tachyphylaxis with overuse. There have been reports of worsening nasal congestion (rebound congestion) when the effects of nasal decongestant sprays or drops containing xylometazoline hydrochloride and oxymetazoline hydrochloride, referred to hereafter as ‘xylometazoline’ and ‘oxymetazoline’, wear [...]

The post MHRA Drug Safety Update: Nasal decongestant sprays and drops containing xylometazoline hydrochloride / oxymetazoline hydrochloride appeared first on Community Pharmacy England.

By |April 30th, 2026|Lexpos News|Comments Off on MHRA Drug Safety Update: Nasal decongestant sprays and drops containing xylometazoline hydrochloride / oxymetazoline hydrochloride

MHRA Class 2 Medicines Recall: Sertraline 100mg film-coated tablets (Amarox Limited)

MHRA Class 2 Medicines Recall: Sertraline 100mg film-coated tablets (Amarox Limited) Drug alert number: EL(26)A/22 Date issued: 28 April 2026 Amarox Limited is recalling one batch of Sertraline 100 mg film-coated tablets as a precautionary measure due to an error at the manufacturing site. DMRC reference number: DMRC-39135670 Company name: Amarox Limited Medicine Details Sertraline 100mg [...]

The post MHRA Class 2 Medicines Recall: Sertraline 100mg film-coated tablets (Amarox Limited) appeared first on Community Pharmacy England.

By |April 28th, 2026|Lexpos News|Comments Off on MHRA Class 2 Medicines Recall: Sertraline 100mg film-coated tablets (Amarox Limited)

Extended FP34C submission deadline for prescriptions dispensed in April 2026

With Early May Bank Holiday (4 May 2026) occurring in the first five days of the FP34C submission window, pharmacy owners will have an extra day, until the end of 6 May 2026, to submit their April FP34Cs using the Manage Your Service (MYS) portal and to dispatch their prescription bundle to the relevant pricing division [...]

The post Extended FP34C submission deadline for prescriptions dispensed in April 2026 appeared first on Community Pharmacy England.

By |April 24th, 2026|Lexpos News|Comments Off on Extended FP34C submission deadline for prescriptions dispensed in April 2026

Retrospective reimbursement prices for April 2026

Following representations made by Community Pharmacy England on behalf of community pharmacy owners, the Department of Health and Social Care (DHSC) has redetermined April 2026 reimbursement prices for the following products to reflect an increase in their NHS list prices. To avoid pharmacy owners dispensing these products at a loss, DHSC has agreed to grant retrospective price [...]

The post Retrospective reimbursement prices for April 2026 appeared first on Community Pharmacy England.

By |April 23rd, 2026|Lexpos News|Comments Off on Retrospective reimbursement prices for April 2026

SSP for Ramipril 1.25mg capsules issued

In response to a significant ongoing disruption to the supply of Ramipril 1.25mg capsules, a Serious Shortage Protocol (SSP) has been issued by the Department of Health and Social Care (DHSC). Effective today 22nd April 2026, SSP087 provides that where supplies are available, but the prescription is for more than one month’s supply the total quantity [...]

The post SSP for Ramipril 1.25mg capsules issued appeared first on Community Pharmacy England.

By |April 22nd, 2026|Lexpos News|Comments Off on SSP for Ramipril 1.25mg capsules issued